Loading...
XSHE
002513
Market cap220mUSD
Apr 30, Last price  
4.28CNY
1D
-3.39%
1Q
1.90%
Jan 2017
-73.58%
IPO
-77.99%
Name

Jiangsu Lanfeng Bio-chemical Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
0.92
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.84%
Rev. gr., 5y
3.29%
Revenues
1.74b
+20.51%
550,598,351908,081,407627,542,583914,109,2531,143,272,6221,268,549,9511,372,077,3341,252,062,1681,010,416,2121,456,688,7061,850,640,8891,481,392,1331,504,434,6631,341,970,8911,443,932,1441,445,239,9891,741,628,407
Net income
0k
30,098,91697,825,67998,906,18176,821,29883,464,84559,230,65021,101,73400107,180,58135,446,7840014,823,557000
CFO
-383m
68,242,77096,752,923128,032,42070,521,86419,570,67358,878,64754,682,858127,973,626250,843,669335,700,62755,327,10173,297,827255,079,830128,305,65311,796,5570-383,302,095
Dividend
Jun 13, 20170.04 CNY/sh
Earnings
May 23, 2025

Profile

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.
URL
https://www.jslanfeng.com/
IPO date
Dec 03, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,741,628
20.51%
1,445,240
0.09%
Cost of revenue
1,926,762
1,503,285
Unusual Expense (Income)
NOPBT
(185,133)
(58,045)
NOPBT Margin
Operating Taxes
(6,597)
73,724
Tax Rate
NOPAT
(178,537)
(131,769)
Net income
Dividends
(12,065)
Dividend yield
0.47%
Proceeds from repurchase of equity
(11,685)
101,550
BB yield
0.45%
-5.78%
Debt
Debt current
212,639
108,271
Long-term debt
409,402
263
Deferred revenue
114,107
6,161
Other long-term liabilities
106,300
72,543
Net debt
164,698
72,231
Cash flow
Cash from operating activities
(383,302)
CAPEX
Cash from investing activities
(536,786)
Cash from financing activities
925,944
47,828
FCF
(698,152)
102,132
Balance
Cash
457,343
24,002
Long term investments
2
12,300
Excess cash
370,262
Stockholders' equity
(1,497,100)
373,936
Invested Capital
2,589,732
539,934
ROIC
ROCE
EV
Common stock shares outstanding
372,865
340,086
Price
6.92
33.85%
5.17
3.61%
Market cap
2,580,229
46.75%
1,758,246
3.61%
EV
3,019,382
1,845,811
EBITDA
(86,912)
37,770
EV/EBITDA
48.87
Interest
29,689
13,555
Interest/NOPBT